Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon May 09, 2019 3:14am
144 Views
Post# 29727455

RE:Way to go Cam :) Thanks

RE:Way to go Cam :) ThanksI believe the consensus estimate for Aurora's 2019 Q3 sales revenue is somewhere around $79M or thereabouts.  Apparently, I read somewhere that this might even be a reduction from the $90M mark which some of the analysts had Aurora coming in at a few weeks ago.  Not sure if this is true or not, but it would not totally surprise me considering the fact that overall sales in the cannabis stores throughout Canada has apparently dropped for 2 consecutive months in a row.

So, not sure if we will hit the $79M mark or not.  Definitely still a big YOY gain as compared to the meagre $16.1M that the company was able to put up for 2018 Q3.  Of course, those results were without the CMED and Leaf numbers in there.  Not entirely sure if this expected $79M estimate is for total gross revenue or total net revenue which came in at $62M and $54.2M respectively for the previous Q2.  So, if we do hit the consensus mark of $79M, it would represent either a sequential quarter over quarter percentage of either 23% or 45%.

Not sure if these sales percentage increases would be enough to satisfy the investors and move the stock price up accordingly.  Somehow, I think the only sure fire way to see any kind of significant increase in the stock price next Wednesday would be for them to announce some kind of partnership deal along with the release of the financials.  Similar to what Canopy did with the Constellation announcement when they released those horrid fiancials which everybody forgot about immediately.  If they don't, I am afraid the longs will have to wait another 3 months to hope for any chance of a significant upward movement in the share price.

Well, at least that's my current view of the situation, so GLTA!!!
mozzarella wrote: In Aurora’s case, last quarter the company issued a big warning before earnings. The mere absence of that for Q3 might suggest that it isn’t anticipating as big of a letdown for investors, and that alone is a good sign. There’s nothing like a big sales miss to spook cannabis investors. And with this coming quarter including a full three months of recreational sales, it’s likely going to be a "great quarter for Aurora"


Bullboard Posts